Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178152 · ClinicalTrials.gov registry record
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 334
- Enrollment target
NCT00178152 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 334 participants.
The verdict
NCT00178152 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 334 participants
- Enrollment target
Study Summary
Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2005-05 |
| Est. Completion | 2005-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178152
The ClinicalTrials.gov registry entry for NCT00178152 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 334 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00178152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00178152 about?
NCT00178152 is a clinical study titled "Erythema Toxicum Neonatorum in Newborns and the Development of Asthma". Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of re...
What is the current status of trial NCT00178152?
This trial is currently completed. The enrollment target is 334 participants. The study started on 2005-05. Estimated completion is 2005-11.
Who is sponsoring clinical trial NCT00178152?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.